PharmaCielo Achieves Colombian GMP Certification For Phytotherapeutics

PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) said Tuesday that it has received Colombian GMP Certification for Phytotherapeutics manufactured with its extracts and proprietary cultivars from the Colombian National Food and Drug Surveillance Institute.

Bill Petron, CEO of the Toronto-based parent company of PharmaCielo Colombia Holdings SAS, said the "achievement of this milestone confirms that the company's processes and products are world-class."

The …

Full story available on Benzinga.com

More PharmaCielo Achieves Colombian GMP Certification For Phytotherapeutics